ULTRAGENYX PHARMACEUTICAL INC. (RARE)

25.61 -2.48% (-0.65)

Over 1M: +2.8%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

24 26 28
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 81.6M Q3 '21 — Operating Cash Flow: -59.6M Q3 '21 — Free Cash Flow: -80.2M Q3 '21 — Net Income: -73M Q4 '21 — Revenue: 83.4M Q4 '21 — Operating Cash Flow: -54.3M Q4 '21 — Free Cash Flow: -70.4M Q4 '21 — Net Income: -122.5M Q1 '22 — Revenue: 79.9M Q1 '22 — Operating Cash Flow: -117.5M Q1 '22 — Free Cash Flow: -149.7M Q1 '22 — Net Income: -152.3M Q2 '22 — Revenue: 89.3M Q2 '22 — Operating Cash Flow: -77.3M Q2 '22 — Free Cash Flow: -108.2M Q2 '22 — Net Income: -158.2M Q3 '22 — Revenue: 90.7M Q3 '22 — Operating Cash Flow: -95.3M Q3 '22 — Free Cash Flow: -121.4M Q3 '22 — Net Income: -245.1M Q4 '22 — Revenue: 103.3M Q4 '22 — Operating Cash Flow: -90.3M Q4 '22 — Free Cash Flow: -117.3M Q4 '22 — Net Income: -151.8M Q1 '23 — Revenue: 100.5M Q1 '23 — Operating Cash Flow: -156.9M Q1 '23 — Free Cash Flow: -181.9M Q1 '23 — Net Income: -164M Q2 '23 — Revenue: 108.3M Q2 '23 — Operating Cash Flow: -116.2M Q2 '23 — Free Cash Flow: -130.1M Q2 '23 — Net Income: -159.8M Q3 '23 — Revenue: 98.1M Q3 '23 — Operating Cash Flow: -117.9M Q3 '23 — Free Cash Flow: -121.6M Q3 '23 — Net Income: -159.6M Q4 '23 — Revenue: 127.1M Q4 '23 — Operating Cash Flow: -84.1M Q4 '23 — Free Cash Flow: -85.4M Q4 '23 — Net Income: -123.6M Q1 '24 — Revenue: 108.8M Q1 '24 — Operating Cash Flow: -190.7M Q1 '24 — Free Cash Flow: -193.9M Q1 '24 — Net Income: -170.7M Q2 '24 — Revenue: 147M Q2 '24 — Operating Cash Flow: -77M Q2 '24 — Free Cash Flow: -79M Q2 '24 — Net Income: -131.6M Q3 '24 — Revenue: 139.5M Q3 '24 — Operating Cash Flow: -67M Q3 '24 — Free Cash Flow: -68.6M Q3 '24 — Net Income: -133.5M Q4 '24 — Revenue: 164.6M Q4 '24 — Operating Cash Flow: -79.3M Q4 '24 — Free Cash Flow: -79.5M Q4 '24 — Net Income: -133.2M Q1 '25 — Revenue: 139M Q1 '25 — Operating Cash Flow: -166M Q1 '25 — Free Cash Flow: -167M Q1 '25 — Net Income: -151M Q2 '25 — Revenue: 167M Q2 '25 — Operating Cash Flow: -109M Q2 '25 — Free Cash Flow: -112M Q2 '25 — Net Income: -115M Q3 '25 — Revenue: 159.9M Q3 '25 — Operating Cash Flow: -91.2M Q3 '25 — Free Cash Flow: -92.2M Q3 '25 — Net Income: -180.4M Q4 '25 — Revenue: 207.3M Q4 '25 — Operating Cash Flow: -99.8M Q4 '25 — Free Cash Flow: -100.8M Q4 '25 — Net Income: -128.6M Q1 '26 — Revenue: 136M Q1 '26 — Operating Cash Flow: -197M Q1 '26 — Free Cash Flow: -198M Q1 '26 — Net Income: -185M Q2 '26 — Revenue: 214M Q2 '26 — Operating Cash Flow: -97M Q2 '26 — Free Cash Flow: -98M Q2 '26 — Net Income: -92M -200M -100M 0 100M 200M 300M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.6
SBC / sales 15.1%
OE margin -83.3%
Oper. margin -73.6%
Accruals -8.0%
EBITDA margin -69.0%
FCF margin -68.2%
OCF margin -67.6%
Profit margin -81.7%
ROA -46.4%
ROCE -57.9%
Gross margin —
OCF / EBIT —
ROE —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.7
RPO / sales —
RPO growth —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

4.8
ND/EBITDA —
Cash runway 0.6 yr
Debt payback 0.0 yr
Quick ratio 1.6×
F-score 5.1 pts
Cash / Debt —
Debt / Eq —
Equity / Assets —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.2
Sales CAGR 4Y +17.6%
Sales/sh Y/Y +7.9%
Sales Q/Q +28.1%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.